UA86051C2 - Substituted quinoline compounds - Google Patents
Substituted quinoline compoundsInfo
- Publication number
- UA86051C2 UA86051C2 UAA200608717A UAA200608717A UA86051C2 UA 86051 C2 UA86051 C2 UA 86051C2 UA A200608717 A UAA200608717 A UA A200608717A UA A200608717 A UAA200608717 A UA A200608717A UA 86051 C2 UA86051 C2 UA 86051C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- substituted quinoline
- quinoline compounds
- compositions
- mtp
- Prior art date
Links
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
This invention relates to MTP/Apo В secretion inhibitors of Formula (I) wherein R-R, X, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.(I)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54167804P | 2004-02-04 | 2004-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA86051C2 true UA86051C2 (en) | 2009-03-25 |
Family
ID=37722570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200608717A UA86051C2 (en) | 2004-02-04 | 2005-01-24 | Substituted quinoline compounds |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN1914195A (en) |
| GT (1) | GT200500016A (en) |
| TN (1) | TNSN06247A1 (en) |
| UA (1) | UA86051C2 (en) |
| ZA (1) | ZA200605575B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE551339T1 (en) | 2003-11-05 | 2012-04-15 | Sarcode Bioscience Inc | MODULATORS OF CELLULAR ADHESION |
| ES2830024T3 (en) | 2007-10-19 | 2021-06-02 | Novartis Ag | Compositions and methods for the treatment of macular edema |
| CN104844509A (en) * | 2014-02-14 | 2015-08-19 | 河南工业大学 | Mild-condition and metal-free method for preparing aminoquinoline derivatives |
-
2005
- 2005-01-24 UA UAA200608717A patent/UA86051C2/en unknown
- 2005-01-24 CN CN 200580004041 patent/CN1914195A/en active Pending
- 2005-01-28 GT GT200500016A patent/GT200500016A/en unknown
-
2006
- 2006-07-06 ZA ZA200605575A patent/ZA200605575B/en unknown
- 2006-08-04 TN TNP2006000247A patent/TNSN06247A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200605575B (en) | 2008-01-30 |
| TNSN06247A1 (en) | 2007-12-03 |
| GT200500016A (en) | 2005-08-18 |
| CN1914195A (en) | 2007-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20084360B (en) | Substituted quinoline compounds | |
| MX2009006195A (en) | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use. | |
| TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
| UA83875C2 (en) | Quinoline derivatives for use as mycobacterial inhibitors | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| ZA200703002B (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
| TNSN08373A1 (en) | Azolopyrimidines as inhibitors of cannabinoid 1 activity | |
| NO20084652L (en) | Deazapurins useful as inhibitors of januskinases | |
| WO2006106326A8 (en) | Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors | |
| MXPA05013224A (en) | Pyridinyl carbamates as hormone-sensitive lipase inhibitors. | |
| PT1902037E (en) | 2,4-diamino-pyrimidines used as aurora inhibitors | |
| TN2009000128A1 (en) | Dihydropyridine derivatives useful as protein kinase inhibitors | |
| TW200510416A (en) | P38 inhibitors and methods of use thereof | |
| WO2008013987A3 (en) | N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones | |
| TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| MX2009003981A (en) | Calcium receptor modulating agents. | |
| EA201170344A1 (en) | AZAINDOL IAP INHIBITORS | |
| NO20073839L (en) | Quinoline derivative, method of preparation and use thereof, and drug containing it | |
| ATE466841T1 (en) | 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS | |
| GB0407025D0 (en) | Novel compounds | |
| NO20055563L (en) | Means for the treatment of lower abdominal disorders | |
| WO2007076087A3 (en) | 3-aryl-substituted quinazolones, and uses thereof | |
| ATE419249T1 (en) | INHIBITORS OF MITOTIC KINESIN | |
| ES2333026T3 (en) | DERIVED FROM CICLOHEXIL-1,4-DIAMINE SUBSTITUTED. | |
| DE602005014632D1 (en) | PYRROL-BZW. IMIDAZOLAMIDE FOR THE TREATMENT OF OBESITAS |